- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Aspire Biopharma authorizes $5 million stock buyback program | 6 | Investing.com | ||
| Mo | Aspire Biopharma genehmigt Aktienrückkaufprogramm über 5 Millionen US-Dollar | 2 | Investing.com Deutsch | ||
| ASPIRE BIOPHARMA Aktie jetzt für 0€ handeln | |||||
| Mo | Aspire Biopharma announces $5M share repurchase program | 3 | Seeking Alpha | ||
| Mo | Aspire Biopharma Holdings, Inc.: Aspire Biopharma Announces $5.0 Million Share Repurchase Program | 404 | ACCESS Newswire | ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery... ► Artikel lesen | |
| 20.04. | Aspire Biopharma: $21 Million Private Placement Closed To Support DCS Acquisition And Growth Strategy | 3 | pulse2.com | ||
| 20.04. | Aspire Biopharma Holdings, Inc.: Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition | 320 | ACCESS Newswire | Company secures Commitment Letter from a leading financial institution of up to $22.5M to finance proposed acquisition of Dura Control Systems (DCS)LOI to acquire DCS, a leading global automotive supplier... ► Artikel lesen | |
| 17.04. | Aspire Biopharma Holdings, Inc.: Aspire Biopharma's Buzz Bomb Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo | 779 | ACCESS Newswire | Elite Ultra-Marathoner targets her second World Record in two months following historicUltra Jackpot 100 Win ESTERO, FL / ACCESS Newswire / April 17, 2026 / Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP)... ► Artikel lesen | |
| 16.04. | Aspire Biopharma: Aktionäre genehmigen Aktienzusammenlegung und Kapitalerhöhung | 5 | Investing.com Deutsch | ||
| 16.04. | Aspire Biopharma signs letter of intent to acquire DCS for $30M | 2 | Investing.com | ||
| 16.04. | Aspire Biopharma plant Übernahme von Automobilzulieferer DCS für 30 Mio. US-Dollar | 1 | Investing.com Deutsch | ||
| 16.04. | Aspire Biopharma Holdings, Inc.: Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue | 401 | ACCESS Newswire | ESTERO, FL / ACCESS Newswire / April 16, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery... ► Artikel lesen | |
| 15.04. | Aspire Biopharma Holdings, Inc.: Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion | 298 | ACCESS Newswire | Interwest to Drive Regional Growth for BUZZ BOMB Across Major Grocery and Convenience Channels ESTERO, FL / ACCESS Newswire / April 15, 2026 / Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire"... ► Artikel lesen | |
| 15.04. | Aspire Biopharma unterzeichnet Absichtserklärung zur Übernahme der DCS-Sparte | 6 | Investing.com Deutsch | ||
| 15.04. | Aspire Biopharma Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.04. | Aspire Biopharma Holdings, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 08.04. | Aspire Biopharma Holdings, Inc. - 10-K/A, Annual Report | - | SEC Filings | ||
| 19.03. | Aspire Biopharma Holdings, Inc.: Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion | 291 | ACCESS Newswire | Agreement Set to Expand BUZZ BOMB Distribution Across Natural, Specialty, and Mass Merchandiser Channels ESTERO, FL / ACCESS Newswire / March 19, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)... ► Artikel lesen | |
| 17.03. | Aspire Biopharma Holdings, Inc.: Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director | 655 | ACCESS Newswire | ESTERO, FL / ACCESS Newswire / March 17, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire"), wholly owned subsidiary, Buzz Bomb Caffeine Company, has appointed 25-year industry veteran... ► Artikel lesen | |
| 12.03. | Aspire Biopharma Holdings, Inc.: Aspire Biopharma's Subsidiary to Feature BUZZ BOMB at The Health & Fitness Show 2026 | 310 | ACCESS Newswire | ESTERO, FL / ACCESS Newswire / March 12, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire"), wholly owned subsidiary, Buzz Bomb Caffeine Company, announces its participation at The Health... ► Artikel lesen | |
| 10.03. | Aspire Biopharma Holdings, Inc.: Aspire Biopharma's BUZZ BOMB Disrupts Energy Category with New Convenience Store Pack | 418 | ACCESS Newswire | Convenient Size at the Convenience Store ESTERO, FL / ACCESS Newswire / March 10, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire"), today announced that its subsidiary, Buzz Bomb Caffeine... ► Artikel lesen |
1 2 3 4 5 Weiter >>
91 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| APTORUM GROUP | 0,912 | +4,83 % | Aptorum Group Ltd - S-4/A, Registration of securities, business combinations | ||
| CHINA HEALTH GROUP INC | 0,005 | 0,00 % | C HEALTH GP (08225): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | ||
| ETON PHARMACEUTICALS | 28,910 | +19,86 % | Eton Pharmaceuticals relaunches HEMANGEOL (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution | HEMANGEOL is now available exclusively through Anovo Specialty Pharmacy to streamline access and therapy initiationEton has integrated full Eton Cares patient support, including $0 co-pay for eligible... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 86,91 | -1,18 % | Bright Minds Biosciences Announces Closing of US$175 Million Public Offering | NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company") today closed its recently announced public offering of 1,945... ► Artikel lesen | |
| LB PHARMACEUTICALS | 31,355 | -1,12 % | This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday | ||
| BIOHAVEN | 9,630 | +0,57 % | Biohaven Ltd.: Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results | Prioritizing three key, late-stage clinical programs including Molecular Degrader of Extracellular Proteins (MoDETM) and Targeted Removal of Aberrant Protein (TRAPTM)... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 13,390 | -1,83 % | KAZIA THERAPEUTICS LTD - 6-K, Report of foreign issuer | ||
| AQUESTIVE THERAPEUTICS | 4,190 | +2,07 % | Vergessene Biotech-Chance: Kann Aquestive Therapeutics vor dem Durchbruch stehen? | Aquestive Therapeutics steht trotz operativer Fortschritte und potenziell wertvoller Pipeline unter massivem Bewertungsdruck. Die Aktie notiert deutlich unter früheren Kursniveaus, während sich fundamentale... ► Artikel lesen | |
| GRACE THERAPEUTICS | 2,340 | +4,46 % | Weekly Buzz: Sanofi, Regeneron Pharmaceuticals Get FDA Nod; It's A No For AbbVie, Grace Therapeutics; Eli Lilly Acquires Kelonia | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S. and Europe, alongside FDA rejections, acquisitions, and positive data readouts spanning... ► Artikel lesen | |
| SHUTTLE PHARMACEUTICALS | 0,708 | -31,93 % | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation | Gaithersburg, Maryland--(Newsfile Corp. - May 1, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| OMNIAB | 1,400 | +0,72 % | OmniAb (OABI) Well-Positioned for Momentum Build-Up in 2026 | ||
| MILESTONE PHARMACEUTICALS | 1,870 | +3,89 % | Milestone Pharmaceuticals Inc.: Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST (etripamil) Nasal Spray for the Treatment of PSVT | FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVTParticipants using CARDAMYST in clinical studies were 2x more likely to convert symptomatic... ► Artikel lesen | |
| JOURNEY MEDICAL | 5,185 | +0,68 % | Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights | Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi generated net revenues of $14.7 million during the full-year period after its launch in early April 2025 Approximately... ► Artikel lesen | |
| DARE BIOSCIENCE | 2,350 | +3,07 % | Daré Bioscience, Inc.: Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update | Company Highlights Commercial Launch of DARE to PLAY Sildenafil Cream, Pipeline of Women's Health Solutions, and Multiple Near-Term Potential Catalysts Conference Call and Webcast Today at 4:30... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 13,110 | +3,80 % | Generate Biomedicines Prices IPO At $16/shr | WASHINGTON (dpa-AFX) - Generate Biomedicines, Inc. (GENB) on Thursday priced its initial public offering of 25,000,000 shares of stock at $16 per share, raising gross proceeds of $400 million.The... ► Artikel lesen |
Das Unternehmen ASPIRE BIOPHARMA HOLDINGS INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,212 Euro und damit -4,63 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ASPIRE BIOPHARMA HOLDINGS INC finden Sie auf Wallstreet Online.